TRNS

Transcat, Inc. is rated BUY, leveraging recurring revenue from government-mandated calibration services and a strong competitive moat. TRNS's growth is driven by high-margin services, strategic M&A, and recent expansion into Latin America, targeting life sciences and regulated industries. Despite a 58% YTD share price gain, TRNS trades at 18x forward EV/EBITDA, well below its historical peak valuation multiples.

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Announces Appointment of Roy Simmons as Chief Strategy and Corporate Development Officer.

The increasing adoption of industrial automation, focus on higher energy efficiency and optimum resource utilization should drive the Zacks Instruments ??? Control industry.

Transcat, Inc. (TRNS) Q4 2026 Earnings Call Transcript

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Reports Strong Fiscal Fourth Quarter 2026 Financial Results with Continued High Single-Digit Service Organic Revenue* Growth.

Evaluate the expected performance of Transcat (TRNS) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Host Fourth Quarter Fiscal Year 2026 Conference Call and Webcast on Tuesday, May 26, 2026 at 4:30 p.m. Eastern Time.

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of test measurement, control and calibration, today announced the acquisition of SCM Metrology and Laboratories S.A. (“SCM”), a privately-held calibration services provider based in Costa Rica. The transaction closed effective April 9, 2026. The acquisition price of approximately $13 million was paid in cash and is subject to customary adjustments and holdback provisions. This acqui.